KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Debt to Equity (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Debt to Equity for 12 consecutive years, with $1.75 as the latest value for Q4 2025.

  • Quarterly Debt to Equity changed N/A to $1.75 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.75 through Dec 2025, changed N/A year-over-year, with the annual reading at $1.75 for FY2025, N/A changed from the prior year.
  • Debt to Equity hit $1.75 in Q4 2025 for ClearPoint Neuro, down from $1.84 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $1.84 in Q3 2025 to a low of $0.2 in Q4 2021.
  • Historically, Debt to Equity has averaged $0.61 across 4 years, with a median of $0.36 in 2021.
  • Biggest five-year swings in Debt to Equity: crashed 98.08% in 2021 and later skyrocketed 75.2% in 2023.
  • Year by year, Debt to Equity stood at $0.2 in 2021, then surged by 33.0% to $0.27 in 2022, then surged by 75.2% to $0.47 in 2023, then surged by 272.75% to $1.75 in 2025.
  • Business Quant data shows Debt to Equity for CLPT at $1.75 in Q4 2025, $1.84 in Q3 2025, and $1.46 in Q2 2025.